List view / Grid view
7 September 2018 | By Drug Target Review
Researchers have developed a see-through, dual-layered, mesh EEG device which is capable of measuring the electrical activity of individual neurons...
6 September 2018 | By Iqra Farooq (Drug Target Review)
Researchers have developed a PET imaging method suitable for many forms of cancer, with high contrast and less inconvenience to patients...
5 September 2018 | By Del Trezise
Live-cell analysis is now a well-established method that is part of the everyday cell biologist’s armoury for understanding cell biology. For over a decade, the functionality, throughput, and ease of use offered by real-time live-cell analysis has provided a platform for accurate and reproducible cell biology analysis in multiple biomedical…
29 August 2018 | By Drug Target Review
Despite the human genome being first sequenced almost 20 years ago, researchers know comparatively little about how the genome is organised within cells. But a new TSA-Seq technique is changing that.
29 August 2018 | By Drug Target Review
Researchers have identified a novel imaging biomarker, which has been found to be able to predict all-cause and cardiac mortality...
6 August 2018 | By Drug Target Review
Since beta cells and neurological tissues have common receptors, researchers screened brain radioligands for their ability to identify beta cells...
25 July 2018 | By Dimitri Scholz (University College Dublin), Karl Gaff (Dublin Institute of Technology)
The microscope slide is flat (2D), but the world around us is not – despite the flat-earth theories. We need volume information about our samples, ideally with high resolution in all three dimensions as well as over time – the fourth dimension...
25 July 2018 | By Ben Burke (University of Hull and Castle Hill Hospital), Steve Archibald (University of Hull and Castle Hill Hospital)
The world of healthcare is rapidly evolving. With an ageing population, comes a significant increase in cancers, metabolic diseases and neurodegenerative disorders. New drug candidates are required; however drug development remains a lengthy and expensive process, with the average timeline now over 10 years and costs continuing to rise...
20 July 2018 | By Paul Andrews (National Screening Centre - Scientific Lead - Dundee Laboratory)
How times change. Up to 15 years ago, you would be hard-pressed to find a drug discovery conference with a track dedicated to phenotypic approaches. The underpinning science was called high-content imaging or analysis, being mainly confined to academic drug discovery labs and a handful of pioneers in industry. but…
17 July 2018 | By Drug Target Review
Scientists in the U.S. have developed a powerful imaging tool to more accurately reproduce visuals of the brain and investigate mechanisms that precede Alzheimer’s symptoms.
16 July 2018 | By Dr Zara Kassam (Drug Target Review)
Approach could improve understanding of immune system recovery in people treated for HIV infection...
6 July 2018 | By Drug Target Review
Researchers release open source software, connecting and building the neuroscience coding community...
27 June 2018 | By Drug Target Review
New nuclear medicine tracers could help medical researchers find a cure for Alzheimer's and other neurodegenerative diseases.
11 June 2018 | By PerkinElmer
For lead optimisation, target-based assays are still the most affordable means of rapidly performing fast iterations and remain core to screening. However, the desire for biological relevance is driving ongoing growth in cell-based assays.
Send this to a friend
Follow: